Skye Bioscience Financial Overview
Skye Bioscience's market cap is currently $26.75M. The company's EPS TTM is $-0.32; its P/E ratio is -0.65; Skye Bioscience is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
